ORG – Page 254 – Talk Bio

Pharmaceutical Giants Secure Victory in Initial Zantac Lawsuit

1 year ago talkbio0Tagged Boehringer, Heartburn, Ingelheim, NDMA, ranitidine, SmithKline Beecham, victory, Zantac

Zantac, GSK, Boehringer Ingelheim, lawsuit, victory, heartburn medication, ranitidine, NDMA

J&J Adjusts Dosing Strategy for Actinium Prostate Cancer Drug Following Early Study Setbacks

1 year ago talkbio0Tagged Actinium, Cancer Therapeutic Procedure, Cessation of life, Clinical Trials, dosing, Drug Development, Flexible, J&J, Johnson & Johnson, Malignant neoplasm of prostate

J&J, Johnson & Johnson, actinium prostate cancer drug, capped dosing, flexible dosing, patient deaths, early study, clinical trial, cancer treatment, drug development.

Semaglutide Significantly Improves Cardiovascular Health and Reduces Mortality Risk in Kidney Disease Patients, Novo Reports

1 year ago talkbio0Tagged Cardiovascular system, Clinical Trials, Health, Mortality Vital Statistics, Novo, semaglutide

Semaglutide, Novo, cardiovascular health, kidney disease, mortality risk, clinical trial

Revolutionizing Biotherapeutic Analysis: Novel icIEF Fractionation and Mass Spectrometry for Charge Characterization

1 year ago talkbio0Tagged analytical techniques, Biological Factors, biotherapeutics, Characterization, charge amounts, Chemical fractionation, Imaged Capillary Isoelectric Focusing, Protein Analysis, protein charge, Protein Purification, protein separation, therapeutic protein, Variant

biotherapeutics, icIEF fractionation, mass spectrometry, charge characterization, protein analysis, therapeutic proteins, biopharmaceuticals, analytical techniques, protein purification, protein separation, protein charge variants.